Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease

Digestive Diseases and Sciences(2020)10.1007/s10620-020-06226-1Source: DataRank Database

Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease is a research paper published in Digestive Diseases and Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.51)OA: greenTopics (69)Linked Datasets (24)DataCite Reuse (24)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Dandan Xu ORCID,KATHRYN H. SCHMITZ ORCID,Christopher Sciamanna ORCID,Scot R. Kimball ORCID,Jonathan G. Stine ORCID

Live enrichment

PubMed:32239376 PMC:PMC7529701 OpenAlex:https://openalex.org/W3015069880

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: L30 DK118601

National Institutes of Health

Grant: UL1TR000127

National Institutes of Health

Grant: UL1TR002014

NIDDK NIH HHS

Grant: R01 DK013499

National Institutes of Health

Grant: 2UL1TR002014-05A1

Penn State Clinical and Translational Science Institute

National Institutes of Health

Grant: 3UL1TR000127-05S1

Penn State Clinical and Translational Science Institute

FWCI

1.51

Citation Percentile

0.8%

Citation Trend

2020

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7529701

publisherhttp://link.springer.com/content/pdf/10.1007/s10620-020-06226-1.pdf

publisherhttp://link.springer.com/article/10.1007/s10620-020-06226-1/fulltext.html

journalhttps://doi.org/10.1007/s10620-020-06226-1

Fields of Study

Liver Disease Diagnosis and TreatmentMetabolism, Diabetes, and CancerMetabolomics and Mass Spectrometry Studies0301 basic medicine0303 health sciences03 medical and health sciencesAMP-Activated Protein KinasesAdolescentAdultAgedBiopsyBody CompositionExercise TherapyFemaleHumansMaleMechanistic Target of Rapamycin Complex 1Middle AgedNon-alcoholic Fatty Liver DiseasePhosphorylationRibosomal Protein S6

MeSH Terms

Mechanistic Target of Rapamycin Complex 1AdolescentAdultAgedBiopsyBody CompositionExercise TherapyFemaleHumansMaleMiddle AgedPhosphorylationRibosomal Protein S6AMP-Activated Protein KinasesNon-alcoholic Fatty Liver Disease

Keywords

mTORC1AMPKNonalcoholic fatty liver diseaseSteatosisRibosomal protein s6Internal medicineEndocrinologyAMP-activated protein kinaseFatty liverMedicineProtein kinase ASteatohepatitisPhosphorylationBiologyDiseaseBiochemistryProtein phosphorylationMechanismFitnessPhysical ActivityAdultMaleAdolescentBiopsyAMP-Activated Protein KinasesMechanistic Target of Rapamycin Complex 1Middle AgedExercise TherapyNon-alcoholic Fatty Liver DiseaseBody CompositionHumansFemaleAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.24742024.v1figshare

Additional file 1 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.24742024figshare

Additional file 2 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.24742940.v1figshare

Additional file 2 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.24742940figshare

Additional file 10 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649228.v1figshare

Additional file 10 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649228figshare

Additional file 11 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649231.v1figshare

Additional file 11 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649231figshare

Additional file 1 of Motor skill learning modulates striatal extracellular vesicles’ content in a mouse model of Huntington’s disease

10.6084/m9.figshare.26732530.v1figshare

Additional file 1 of Motor skill learning modulates striatal extracellular vesicles’ content in a mouse model of Huntington’s disease

10.6084/m9.figshare.26732530figshare

Additional file 9 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649225.v1figshare

Additional file 8 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649222.v1figshare

Additional file 8 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649222figshare

Additional file 9 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649225figshare

Additional file 7 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649219.v1figshare

Additional file 7 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649219figshare

Additional file 6 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649216.v1figshare

Additional file 5 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649213.v1figshare

Additional file 6 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649216figshare

Additional file 3 of Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway

10.6084/m9.figshare.26649207figshare